Medscape Launches Newly Designed iPad App

Medscape app updated with new design and tools to deepen physician experience

NEW YORK, Jan. 22, 2013 /PRNewswire/ -- Medscape from WebMD (Nasdaq: WBMD), the leading source of clinical news, health information and point-of-care tools for healthcare professionals, has released a new design and enhanced features for its Medscape app for the iPad® and iPad® mini. Medscape is the highest-rated and fastest-growing free medical app among physicians, providing vital information for clinicians at the point of care.

Medscape has approximately 3 million registered app users. Medscape's suite of mobile clinical reference tools conveniently assists physicians and other healthcare providers through their preferred mobile device. Included in the free Medscape app are formulary information, medical calculators, drug, disease and condition references, and a drug interaction checker. Intuitive and easy to search and navigate, the app provides the latest medical news, keeping physicians abreast of the most important news impacting their practices. In addition, the app offers continuing medical education and training to meet licensure requirements.

From streamlined content updates to full optimization across the multi-screen platform, Medscape continues to innovate to better serve the needs of physicians and healthcare providers. The Medscape app provides current and comprehensive reference information along with clinical multimedia content. With insights from leading academic thought leaders and Medscape CME courses from the leading provider of online CME, healthcare providers can use the Medscape app for a broad range of professional purposes.

"There is a growing trend among healthcare providers in all specialties to integrate mobile devices into their daily workflows to conveniently access information and clinical tools," said Steve Zatz, Executive Vice President for WebMD Professional Services. "Medscape is dedicated to providing decision-making support at the point of care, offering healthcare providers the most robust content and services at no cost."

New features now available on the free Medscape App for the iPad and iPad mini include:

Medical Calculators: Users can access 129 medical calculators covering formulas, scales and classifications directly through the calculator feature. Additionally, there are over 600 drugs in the drug reference with integrated dosing calculators.

Formulary Information: The Medscape app provides clinicians with a complete list of over 1,800 insurance plans across all 50 states. Physicians can save their accepted health plans and have access to the tier status of a particular drug, compare the tier status for drugs in the same class, and know which drugs are covered and least expensive to patients based on their insurance plans, all within the app.

Medscape's industry-leading medical information app is available for free for iPhone®, Android™, iPad®, iPad® mini, and Kindle Fire® devices. Registration for a free Medscape account is accessible through the app or by visiting www.medscape.com. To learn more about the Medscape app, please visit www.medscapemobile.com.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: our expectations concerning market opportunities and our ability to capitalize on them; and the benefits expected from new products or services. These statements speak only as of the date of this press release and are based on our current plans and expectations, and they involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: market acceptance of our products and services; relationships with customers and strategic partners; and changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet and information technology
industries. Further information about these matters can be found in our Securities and Exchange Commission filings.